LaCasce, Ann S.
Dana-Farber Cancer Institute,
United States
2024 Rank: 117133
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 3121 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 117133 | 127627 |
| Total Cites | 10707 | 11984 |
| H-index | 54 | 57 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 137 | 138 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 552 | 608 |
| Number of Single+First+Last Authored Papers | 47 | 47 |
| Total Cites to Single+First+Last Authored Papers | 1068 | 1155 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9077 | 9943 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.21 |
| Self-Citation Percentage |
10.66%
|
|
LaCasce, Ann S.
Dana-Farber Cancer Institute,
United States
2023 Rank: 127066
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4883 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 127066 | 136360 |
| Total Cites | 9309 | 10347 |
| H-index | 48 | 53 |
| Hm-index | 12 | 13 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 126 | 127 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 495 | 541 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 941 | 1017 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7908 | 8620 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.20 |
| Self-Citation Percentage |
10.03%
|
|
LaCasce, Ann S.
Dana-Farber Cancer Institute,
United States
2022 Rank: 136393
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5192 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 136393 | 144308 |
| Total Cites | 8107 | 9026 |
| H-index | 47 | 51 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 112 | 113 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 419 | 462 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 803 | 875 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6916 | 7551 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.20 |
| Self-Citation Percentage |
10.18%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.